Vir Biotechnology Announces New Preclinical Research Demonstrating VIR-7831 Maintains Neutralizing Activity Against the SARS-CoV-2 California Variant

NEXT STORY
Predictmedix and JUICEWORKS Form Strategic Partnership with CONNECTUS Global to Deploy Safe Entry Stations Nationwide
PREV STORY
electroCore, Inc. Announces Regulatory Approval in Canada
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ASLAN Pharmaceuticals to Present at HC Wainwright 20th Annual Global Investment Conference

SINGAPORE, Sept. 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Bavarian Nordic Announces 3:1 Effective Split of American Depositary Shares

COPENHAGEN, Denmark, January 5, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

author_avatar
NASDAQ Market News

Alder BioPharmaceuticals® Names Robert W. Azelby President and Chief Executive Officer

Former executive at Juno Therapeutics and Amgen, Azelby brings deep operational and commercialization expertiseBOTHELL, ...

author_avatar
NASDAQ Market News